Emily Dressler to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications Emily Dressler has written about Clinical Trials, Phase I as Topic.
Connection Strength
1.795
-
Yan D, Tait C, Wages NA, Kindwall-Keller T, Dressler EV. Generalization of the time-to-event continual reassessment method to bivariate outcomes. J Biopharm Stat. 2019; 29(4):635-647.
Score: 0.706
-
Yan D, Wages NA, Dressler EV. Improved adaptive randomization strategies for a seamless Phase I/II dose-finding design. J Biopharm Stat. 2019; 29(2):333-347.
Score: 0.676
-
Van Meter EM, Garrett-Mayer E, Bandyopadhyay D. Dose-finding clinical trial design for ordinal toxicity grades using the continuation ratio model: an extension of the continual reassessment method. Clin Trials. 2012 Jun; 9(3):303-13.
Score: 0.215
-
Van Meter EM, Garrett-Mayer E, Bandyopadhyay D. Proportional odds model for dose-finding clinical trial designs with ordinal toxicity grading. Stat Med. 2011 Jul 30; 30(17):2070-80.
Score: 0.198